How to go about securing the best policy for your insurance in Canada.
Latest News
Watch: Home Insurance in Canada—what’s covered, what’s not, if premiums are rising and more + MORE Oct 11th
Planning your home insurance policy? Wondering if you should add on coverage to your existing coverage? Managing editor Lisa Hannam interviews Morgan Roberts, director of sales at RH Insurance, about what is covered with a typical home insurance policy and what’s not covered, as well as if premium.... More »
How Small Businesses Can Stay Safe Against Cyberattacks + MORE Oct 19th
Today’s cyber thieves aren’t lone hackers working from their basements. Cybercrime increasingly has become full-fledged enterprises, complete with CFOs, HR teams and research and development budgets—and this “professionalization” of cybercrime presents a growing risk for small businesses, .... More »
Amazon, Buffett and JPMorgan join forces on health care Jan 30th
Three of corporate America’s heaviest hitters _ Amazon, Warren Buffett and JPMorgan Chase _ sent a shudder through the health industry Tuesday when they announced plans to jointly create a company to provide their employees with high-quality, affordable care.
The announcement was short on deta.... More »
Mercedes-Benz starts subscription pilot from $1,095 a month Jun 12th
Subscribers can choose any vehicle within their tier with no mileage limitations, and a monthly fee covers insurance, vehicle maintenance and 24-hour roadside assistance..... More »
Tax Benefits of Health Insurance Dec 6th
Personal Health Expenses
In many cases health plan related expenses can be declared as tax deductible expenses when filing
taxes. This is true for both individual plans and employee benefit plans.
According to the Canadian Revenue Agency (CRA), the premiums for a private health insurance plan that
.... More »
Novartis wins US OK for biosimilar version of Amgen’s Enbrel
– canadianbusiness.com
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen’s pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders.
The follow-up version of Enbrel, dubbed Erelzi, was developed by Swiss drug giant Novartis, which would not disclose the planned list price for Erelzi.
Novartis also couldn’t say when the new medicine will be launched by its Sandoz unit, which makes generic drugs and “biosimilars” — nearly identical versions of biologic drugs produced in living cells.
Erelzi is the third biosimilar drug approved by the Food and Drug Administration. It’s also the second approved biosimilar developed by Novartis, and the second that will compete with an Amgen drug.
Enbrel was first approved in 1998. It can cost about $4,000 per month without insurance.
The post Novartis wins US OK for biosimilar version of Amgen’s Enbrel appeared first on Canadian Business – Your Source For Business News.
The follow-up version of Enbrel, dubbed Erelzi, was developed by Swiss drug giant Novartis, which would not disclose the planned list price for Erelzi.
Novartis also couldn’t say when the new medicine will be launched by its Sandoz unit, which makes generic drugs and “biosimilars” — nearly identical versions of biologic drugs produced in living cells.
Erelzi is the third biosimilar drug approved by the Food and Drug Administration. It’s also the second approved biosimilar developed by Novartis, and the second that will compete with an Amgen drug.
Enbrel was first approved in 1998. It can cost about $4,000 per month without insurance.
The post Novartis wins US OK for biosimilar version of Amgen’s Enbrel appeared first on Canadian Business – Your Source For Business News.
